Business Wire

NTHU

18.3.2020 10:02:08 CET | Business Wire | Press release

Share
NTHU Researchers Develop AI App for Generating Catchy Ads

An NTHU interdisciplinary research team led by Associate Professor Wu Shan-hung of the Department of Computer Science, Associate Professor Liu Yi-wen of the Department of Electrical Engineering, and Chair Professor Chang Cheng-shang of the Institute of Communications Engineering has recently developed an automated system for the production of digital advertisements. Based on the information provided by the user, the system generates a variety of images and music, which can be fine-tuned to create the final product, thereby greatly reducing the time and cost of producing an advertisement.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200318005022/en/

Wu and Chang designed a conditional generative adversarial network (CGAN) application which generates an ad based on a large amount of related information harvested from the internet by using artificial intelligence (AI). Afterwards, all that remains to be done is to have an advertising specialist edit the ad and add the finishing touches.

Wu explained that the application performs a social network analysis which determines the most popular elements and user preferences to generate eye-catching digital advertisements and optimal screen layouts. For example, the user enters a photo of a bed set with a circle around the bed, and the system automatically generates a variety of ads highlighting the bed’s unique characteristics.

The application can also generate advertisements with models. For example, the user enters a photo of Keanu Reeves after circling certain features he wants to keep, such as the forehead and eyes, and the system will incorporate these features into a new image with similar characteristics.

Wu's team worked with the startup AppFinca to redesign the webpage for its app called “Flora.” After analysis, the team changed Flora's advertising slogan to “He grows trees, and you grow up,” and also came up with a lively color scheme to replace the rather drab one originally used for the page.

The transformation resulted in Flora shooting up to the top position in the rankings of the Free Productivity Tools of the Apple App Store for Taiwan, outranking even Gmail. AppFinca vice president Sun Zhen-wei said that the cost was only 60% of the original advertising fee.

The application developed by the research team also produces jingles. They collected 600 songs and used them to train the system to generate a jingle based on the lyrics and melody, and the result can be adjusted in terms of pitch, timbre, and rhythm. Even though the jingles generated by the application aren’t likely to be nominated for a Grammy Award, the system significantly speeds up the creative process.

The research team has already published a total of 19 articles on their research, and have also presented their results at various international conferences, including the Conference on Neural Information Processing Systems and the International Conference on Acoustics, Speech, and Signal Processing. They are also conducting negotiations with United Microelectronics, Asus, for commercial application of their system.

Link:

ClickThru

Social Media:

https://www.facebook.com/nthu.tw

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 14:05:00 CEST | Press release

Trained on more than 13,000 patient studies, novel system significantly outperforms existing models by up to 35% A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is d

Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’21.5.2026 14:00:00 CEST | Press release

A growing wave of unsupported solar systems and rising electricity prices are creating strong demand for Otovo’s energy service platform Otovo ASA (“Otovo”), a leading global energy service provider for residential and commercial customers, today announced it has reached 30,000 customers across the U.S. and Europe. A total of 20,000 customers have enrolled in Otovo Care, the Company’s membership-based home and commercial energy service, which is powered by Otovo’s industry-leading AI platform, Endurance™. “Reaching 30,000 customers in less than year is proof positive that home and business owners value their power systems,” said William J. (John) Berger, CEO of Otovo. “The ‘solar service crisis’ that is leaving millions of orphaned energy systems without support is driving strong interest in our Otovo Care membership program. Every day your home or commercial power system is not working, you are throwing money away. Otovo’s rapid response service platform keeps you up and running, ensu

The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 14:00:00 CEST | Press release

New research shows that brands aligned with emotionally heightened moments in live sports can improve ad effectiveness Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The r

Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 14:00:00 CEST | Press release

Precemtabart tocentecan (Precem-TcT) is investigated as a potential first-in-class anti-CEACAM5 ADC, for the treatment of metastatic CRC (mCRC) CEACAM5 is overexpressed in the majority of colorectal tumors (~90%), and requires no patient selection Significant unmet need remains for clinically meaningful innovation in colorectal cancer (CRC), the second leading cause of cancer death worldwide Not intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer

Baszucki Group Funds Oxford University Clinical Trial of Ketogenic Therapy for Early Psychosis21.5.2026 13:00:00 CEST | Press release

Randomized controlled trial will evaluate both symptom progression and underlying biology Baszucki Group today announced a £1.17 million grant to support a randomized controlled trial at the University of Oxford assessing the feasibility, safety, and efficacy of a ketogenic diet for patients at clinical high risk of psychosis (CHR-P). Researchers will test this nutritional therapy's ability to improve patients' mental and physical health. This project builds on a growing body of research suggesting the potential of metabolic therapies in treating serious mental illness. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521877110/en/ Baszucki Group Funds £1.17 Million for University of Oxford Trial of Ketogenic Therapy for Early Psychosis Psychotic disorders carry a massive personal burden and are associated with a lower life expectancy. Psychosis does not develop immediately, but typically emerges following a period of early

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye